SCG2 and Alzheimer disease: For SCG2 and SCG3, likeSCG1, most proteoforms were significantly associated with the AD-DEMversus Frail contrast, with greater abundance in Frail individuals(Figure 5E, Supplementary Figure 8), suggesting a uniquemechanism of dysregulation in Frail individuals with a complex relationshipto AD pathology.